Find 49 companies with promising cash flow potential yet trading below their fair value.
To own QuantumScape, you need to believe its solid state technology and capital light licensing model can eventually convert today’s losses into meaningful, higher margin revenue. Eagle Line’s launch and first customer billings support that narrative, but the reaffirmed 2026 adjusted EBITDA loss of US$250 million to US$275 million keeps cash burn and execution at Eagle Line as the key near term catalyst and the most immediate risk.
The most relevant update here is Eagle Line’s pilot production and initial QSE 5 B1 shipments, because they move QuantumScape from pure R&D into early operational income. That matters directly for the catalyst of converting customer programs into licensing and royalty streams, while testing whether the Cobra plus Eagle Line blueprint can scale without the technical or yield issues that could prolong losses and increase funding needs.
Yet behind the excitement around Eagle Line, there is still the question of how long QuantumScape can fund heavy R&D and cash burn before...
Read the full narrative on QuantumScape (it's free!)
QuantumScape's narrative projects $544.5 million revenue and $33.3 million earnings by 2029. This implies an earnings increase of about $468 million from -$435.1 million today.
Uncover how QuantumScape's forecasts yield a $7.91 fair value, a 4% downside to its current price.
Some of the lowest analysts were assuming just US$26.3 million of revenue and US$1.6 million of earnings by 2029, a much more pessimistic view than the baseline catalysts and a reminder that your own stance on QuantumScape’s risks and potential may shift as Eagle Line’s progress and customer billings continue to evolve.
Explore 30 other fair value estimates on QuantumScape - why the stock might be worth over 10x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English